Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS.
- Authors
- Diekstra, Frank P; Saris, Christiaan G J; van Rheenen, Wouter; Franke, Lude; Jansen, Ritsert C; van Es, Michael A; van Vught, Paul W J; Blauw, Hylke M; Groen, Ewout J N; Horvath, Steve; Estrada, Karol; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G; Robberecht, Wim; Andersen, Peter M; Melki, Judith; Meininger, Vincent; Hardiman, Orla; Landers, John E; Brown, Robert H; Shatunov, Aleksey; Shaw, Christopher E; Leigh, P Nigel; Al-Chalabi, Ammar; Ophoff, Roel A; van den Berg, Leonard H; Veldink, Jan H
- Year
- 2012
- Journal
- PloS one
- PMID
- 22509407
- DOI
- 10.1371/journal.pone.0035333
- PMCID
- PMC3324559
Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disease characterized by loss of upper and lower motor neurons. ALS is considered to be a complex trait and genome-wide association studies (GWAS) have implicated a few susceptibility loci. However, many more causal loci remain to be discovered. Since it has been shown that genetic variants associated with complex traits are more likely to be eQTLs than frequency-matched variants from GWAS platforms, we conducted a two-stage genome-wide screening for eQTLs associated with ALS. In addition, we applied an eQTL analysis to finemap association loci. Expression profiles using peripheral blood of 323 sporadic ALS patients and 413 controls were mapped to genome-wide genotyping data. Subsequently, data from a two-stage GWAS (3,568 patients and 10,163 controls) were used to prioritize eQTLs identified in the first stage (162 ALS, 207 controls). These prioritized eQTLs were carried forward to the second sample with both gene-expression and genotyping data (161 ALS, 206 controls). Replicated eQTL SNPs were then tested for association in the second-stage GWAS data to find SNPs associated with disease, that survived correction for multiple testing. We thus identified twelve cis eQTLs with nominally significant associations in the second-stage GWAS data. Eight SNP-transcript pairs of highest significance (lowest p = 1.27 × 10(-51)) withstood multiple-testing correction in the second stage and modulated CYP27A1 gene expression. Additionally, we show that C9orf72 appears to be the only gene in the 9p21.2 locus that is regulated in cis, showing the potential of this approach in identifying causative genes in association loci in ALS. This study has identified candidate genes for sporadic ALS, most notably CYP27A1. Mutations in CYP27A1 are causal to cerebrotendinous xanthomatosis which can present as a clinical mimic of ALS with progressive upper motor neuron loss, making it a plausible susceptibility gene for ALS.
Study design.For each step, the number of resulting SNP-transcript pairs in cis is shown.
LLM interpretation
This figure is a study design flowchart illustrating a filtering process to identify significant SNP-transcript pairs. It shows a sequential reduction in the number of pairs from eQTL discovery (16,901) through eQTL selection (1,108) and replication (951), resulting in 8 final eQTL results. The process incorporates GWAS discovery (14,167 SNPs with $P_{GWAS} < 0.05$) and GWAS replication (SNPs with $P_{GWAS} < 0.05$ after Bonferroni correction) as integrating steps.
Regional linkage disequilibrium (LD) near the CYP27A1 locus on chromosome 2.Top: the position of GWAS SNPs and RefSeq genes located within the regional LD block are drawn. On the X-axis, genomic position in kb, aligned to NCBI genome build 36 coordinates. On the left Y-axis, −log10(p values) for the strongest cis eQTL association for a gene in the replication data, the vertical position of genes (drawn as arrows) are aligned to this axis and thus represent statistical significance. For one gene (RQCD1), no SNP-transcript pair and, therefore, no eQTL p value was available in our data. This gene is shown as a dashed arrow. On the right Y-axis, −log10(p values) from the replication GWAS analysis for SNPs within the region (black line), SNPs modulating CYP27A1 expression are shown as black dots, other SNPs are grey. Bottom: pairwise linkage disequilibrium for HapMap phase III release 2 SNPs (CEU+TSI populations). The LD plot was created in Haploview v4.2 [50], using the standard D'/LOD color scheme.
LLM interpretation
This figure consists of a genomic plot (top) and a linkage disequilibrium (LD) heat map (bottom) centered on the *CYP27A1* locus on chromosome 2. The top panel displays genomic positions (kb) on the x-axis, with the left y-axis showing $-\log_{10}(p\text{-values})$ for cis-eQTL associations for several genes (represented by arrows) and the right y-axis showing $-\log_{10}(p\text{-values})$ for GWAS SNPs (black line and dots). The bottom panel is a Haploview LD plot using a red-scale D'/LOD color scheme to show pairwise LD between HapMap SNPs across the region.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | 2015 | 25744370 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Novel and rare variants in amyotrophic lateral sclerosis genes identified in Malaysian patients. | Zulhairy-Liong NA et al. | — | 2026 | → |
| Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice. | Rezaei A et al. | — | 2025 | → |
| Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study. | Yan Z et al. | — | 2024 | → |
| Bile Acids Induce Neurite Outgrowth in Nsc-34 Cells via TGR5 and a Distinct Transcriptional Profile. | Ackerman HD et al. | — | 2023 | → |
| Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy. | Suzuki N et al. | — | 2023 | → |
| Molecular Landscape of Pelvic Organ Prolapse Provides Insights into Disease Etiology. | Kluivers KB et al. | — | 2023 | → |
| Bile acids induce neurite outgrowth in NSC-34 cells via TGR5 and a distinct transcriptional profile | Gerhard G et al. | — | 2022 | — |
| Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. | Agrawal I et al. | — | 2022 | → |
| Lipid Metabolic Alterations in the ALS-FTD Spectrum of Disorders. | Godoy-Corchuelo JM et al. | — | 2022 | → |
| A Transcriptomic Meta-Analysis Shows Lipid Metabolism Dysregulation as an Early Pathological Mechanism in the Spinal Cord of SOD1 Mice. | Fernández-Beltrán LC et al. | — | 2021 | → |
| The genetic architecture of ALS. | Shatunov A et al. | — | 2021 | → |
| c.1263+1G>A Is a Latent Hotspot for CYP27A1 Mutations in Chinese Patients With Cerebrotendinous Xanthomatosis. | Jiang J et al. | — | 2020 | → |
| Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population. | Zhang S et al. | — | 2020 | → |
| Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. | Xu L et al. | — | 2020 | → |
| Searching Far and Genome-Wide: The Relevance of Association Studies in Amyotrophic Lateral Sclerosis. | Rich KA et al. | — | 2020 | → |
| [The role of lipids in the pathogenesis of lateral amyotrophic sclerosis]. | Alessenko AV et al. | — | 2020 | → |
| MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. | Katsu M et al. | — | 2019 | → |
| Oxysterol research: a brief review. | Griffiths WJ et al. | — | 2019 | → |
| Genetics of Amyotrophic Lateral Sclerosis. | Ghasemi M et al. | — | 2018 | → |
| Motor neuron disease in inherited neurometabolic disorders. | de Souza PVS et al. | — | 2018 | → |
| Neurosteroids and oxysterols as potential therapeutic agents for glaucoma and Alzheimer's disease. | Ishikawa M et al. | — | 2018 | → |
| Sterol 27-Hydroxylase Polymorphism Significantly Associates With Shorter Telomere, Higher Cardiovascular and Type-2 Diabetes Risk in Obese Subjects. | Pavanello S et al. | — | 2018 | → |
| Defective cholesterol metabolism in amyotrophic lateral sclerosis. | Abdel-Khalik J et al. | — | 2017 | → |
| A genome-wide association study on amyotrophic lateral sclerosis in the Taiwanese Han population. | Chen CJ et al. | — | 2016 | → |
| Bile Acids in Neurodegenerative Disorders. | Ackerman HD et al. | — | 2016 | → |
| C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. | Rizzu P et al. | — | 2016 | → |
| The 'Omics' of Amyotrophic Lateral Sclerosis. | Caballero-Hernandez D et al. | — | 2016 | → |
| Amyotrophic Lateral Sclerosis Genetic Studies: From Genome-wide Association Mapping to Genome Sequencing. | He J et al. | — | 2015 | → |
| Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. | Hancock DB et al. | — | 2015 | → |
| Clinical and genetic basis of familial amyotrophic lateral sclerosis. | Souza PV et al. | — | 2015 | → |
| Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice. | Brenndörfer J et al. | — | 2015 | → |
| Genetics of familial hypercholesterolemia. | Brautbar A et al. | — | 2015 | → |
| A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosis. | Sher RB et al. | — | 2014 | → |
| Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. | Nie S et al. | — | 2014 | → |
| Cholestenoic acids regulate motor neuron survival via liver X receptors. | Theofilopoulos S et al. | — | 2014 | → |
| Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor. | Wuolikainen A et al. | — | 2014 | → |
| Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice. | Zurkinden L et al. | — | 2014 | → |
| From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D. | Pinto JT et al. | — | 2014 | → |
| Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. | van Blitterswijk M et al. | — | 2014 | → |
| Overlap of expression quantitative trait loci (eQTL) in human brain and blood. | McKenzie M et al. | — | 2014 | → |
| Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. | Gordon PH | — | 2013 | → |
| Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. | Freemantle E et al. | — | 2013 | → |
| Association of SNPs of CD40 gene with multiple sclerosis in Russians. | Sokolova EA et al. | — | 2013 | → |
| Clinical neurogenetics: amyotrophic lateral sclerosis. | Harms MB et al. | — | 2013 | → |
| Ethical considerations in the management of amyotrophic lateral sclerosis. | Eisen A et al. | — | 2013 | → |
| Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives. | Trojsi F et al. | — | 2013 | → |